Brief: Conmed Q4 Adjusted EPS USD 1.43 Vs. IBES Estimate USD 1.32
28/01/2026 21:05
Jan 28 (Reuters) - Conmed Q4 sales USD 373.198 million vs. IBES estimate USD 366.8 million. Q4 pretax profit USD 29.253 million Q4 income from operations USD 36.623 million Q4 EPS USD 0.54 Q4 net income USD 16.739 million outlook FY revenue USD 1,345-1,375 million outlook FY adjusted EPS USD 4.3-4.45
Recent news on Conmed
See all newsU.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Conmed Corp reports results for the quarter ended June 30 - Earnings Summary
Conmed Q2 sales, adjusted profit beat on organinc platform growth
Brief: Conmed Q2 Adjusted EPS USD 1.38 Vs. IBES Estimate USD 1.11
Brief: Conmed Is Said To Weigh Sale After Takeover Interest- Bloomberg News